611 matches for your search in the start-up spotlight
rss
ESTER Biotech is a Spin-Off of Leipzig University and its idea was born in the Biocity of Leipzig in 2022. We believe that enzymatic recycling will fundamentally change plastic waste management. By breaking down plastics at a molecular level, enzymes enable a truly circular economy. They ...
ESTER Biotech is a Spin-Off of Leipzig University and its idea was born in the Biocity of Leipzig in 2022. We believe that enzymatic recycling will fundamentally change plastic waste management. By breaking down plastics at a molecular level, enzymes enable a truly circular economy. They ...
Cambridge-based TRIMTECH Therapeutic’s mission is to create novel small molecule degraders of protein aggregates that will combat neurodegenerative and inflammatory diseases including Alzheimer’s disease, a leading cause of death globally. The Company’s proprietary degrader technology is focused ...
Headquartered in Seattle and Singapore, Callio Therapeutics is focused on realizing the promise of multi-payload antibody-drug conjugates to transform cancer patient outcomes. The company is developing next-generation, multi-payload antibody-drug conjugates (ADCs) that feature differentiated ...
REPLOID Group AG is an international and innovative biotechnology company that aims to convert organic, low-value biomass through the use of insects on an industrial scale with unprecedented efficiency for the animal feed industry, helping to make our planet greener by reducing waste and gas ...
REPLOID Group AG is an international and innovative biotechnology company that aims to convert organic, low-value biomass through the use of insects on an industrial scale with unprecedented efficiency for the animal feed industry, helping to make our planet greener by reducing waste and gas ...
ACARYON is your partner for the identification, development and optimization of probiotic strains, prebiotic approaches and microbiome applications.
ACARYON is your partner for the identification, development and optimization of probiotic strains, prebiotic approaches and microbiome applications.
We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient ...
NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Cancer Center Karolinska at Karolinska University Hospital, Solna, Sweden. Our vision is to ...
